Valid publication:
Suresh G, Sailaja B, Ashif A, Dave BP, Sasikala C, Ramana CV. Description of Rhodobacter azollae sp. nov. and Rhodobacter lacus sp. nov. Int J Syst Evol Microbiol 2017; 67:3289-3295. 🇮🇳
IJSEM list:
Oren A, Garrity GM. Notification list. Notification that new names and new combinations have appeared in volume 67, part 9 of the IJSEM. Int J Syst Evol Microbiol 2017; 67:4881-4883.
Nomenclatural status:
validly published under the ICNP
Taxonomic status:
correct name (and explicitly recommended for medical use)
Risk group:
1
Notes:
😢 The terminology used by the authors is in line with many other taxonomic studies and does not negatively affect their main results; some improvements may nevertheless be possible. Contrasting the term "chemotaxonomic" with "phenotypic" is not recommended. Whether taxa can have "members" is debatable. See the LPSN phylogeny page for details.Publication:
Göker M. What can genome analysis offer for bacteria? In: Bridge P, Smith D, Stackebrandt E (eds), Trends in the systematics of bacteria and fungi, CAB International, Wallingford, 2021, p. 255-281. 🇬🇧
😷 The risk group for Germany has been imported on 2023-10-29. The full classification is: risk group = 1. — If in doubt, use the risk group given in the regulations for your country and, if these are not available, use the risk group given in the catalogue of the culture collection from which you have obtained or intend to obtain the strain.
🎓 Name mentioned 1 time in PubMed until 2026-06-11.
🙆 This name is on the List of Recommended Names for bacteria of medical importance (LoRN) as the name to be applied to this species. The name is on LoRN because of the recorded pathogenicity of other species in the genus.